Sevelamer, Ca×P product and vitamin D
- 1 February 2001
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 16 (2) , 429-430
- https://doi.org/10.1093/ndt/16.2.429
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*Nephrology Dialysis Transplantation, 1999
- Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?Kidney International, 1999
- Importance of vitamin D repletion in uraemiaNephrology Dialysis Transplantation, 1999
- RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormoneKidney International, 1999
- Chronic metabolic correction in haemodialysed patients actually has a direct suppressive effect on PTH secretion. Another view of published dataNephrology Dialysis Transplantation, 1997
- Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.Journal of Clinical Investigation, 1996
- Vitamin DThe Lancet, 1995